Cape ANN Savings Bank Buys 165 Shares of Stryker Corporation $SYK

Cape ANN Savings Bank boosted its stake in Stryker Corporation (NYSE:SYK) by 6.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,611 shares of the medical technology company’s stock after acquiring an additional 165 shares during the quarter. Cape ANN Savings Bank’s holdings in Stryker were worth $1,033,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SYK. Brighton Jones LLC lifted its holdings in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares in the last quarter. Portside Wealth Group LLC lifted its stake in Stryker by 16.0% in the 1st quarter. Portside Wealth Group LLC now owns 682 shares of the medical technology company’s stock valued at $246,000 after acquiring an additional 94 shares in the last quarter. Retirement Planning Group LLC bought a new stake in Stryker in the 1st quarter valued at approximately $212,000. Breakwater Capital Group lifted its stake in Stryker by 31.5% in the 1st quarter. Breakwater Capital Group now owns 2,123 shares of the medical technology company’s stock valued at $790,000 after acquiring an additional 508 shares in the last quarter. Finally, Vest Financial LLC bought a new stake in Stryker in the 1st quarter valued at approximately $203,000. 77.09% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Evercore ISI boosted their price objective on shares of Stryker from $390.00 to $415.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 8th. Wells Fargo & Company boosted their price target on shares of Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Rothschild & Co Redburn assumed coverage on shares of Stryker in a research report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target on the stock. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Stryker in a report on Saturday, September 27th. Fifteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus price target of $430.33.

Stryker Stock Up 1.1%

Shares of SYK stock opened at $370.59 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The firm’s 50-day moving average is $382.81 and its 200-day moving average is $378.92. The stock has a market cap of $141.68 billion, a price-to-earnings ratio of 49.08, a PEG ratio of 2.64 and a beta of 0.94. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Sell-side analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is 44.50%.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total value of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares of the company’s stock, valued at $1,212,962,556.60. This represents a 5.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Viju Menon sold 500 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the transaction, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is owned by corporate insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.